Business · 21/01/2016Updated: 10/17/2026 · 1 min read
FDA Releases Guidance on Implanted Blood Access Devices for Hemodialysis
Summary
The FDA has made available a guidance document to help industry prepare for the reclassification of implanted blood access devices for hemodialysis, a process that will require premarket notification submissions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →